Literature DB >> 23255888

Superficial spreading squamous cell carcinoma of the uterine cervix involving the endometrium: Report of two cases with emphasis on the likely molecular mechanism.

Mitsuaki Ishida1, Hidetoshi Okabe.   

Abstract

Squamous cell carcinoma (SCC) of the cervix generally invades directly into the uterine wall, but in rare cases it spreads superficially to the inner surface of the uterus, thereby replacing the endometrium. This type is called superficial spreading SCC. In the present study we report two cases of this unusual form of cervical SCC and discuss the possible molecular mechanism involved. Two females, aged 64 (case 1) and 59 (case 2) years old, presented with post-menopausal vaginal bleeding. Histopathological studies of the resected specimens revealed non-keratinizing SCC of the cervix (pTIIA1 in case 1 and pTIIB in case 2). A notable finding in the two tumors was that atypical squamous cells were extending and replacing the endometrium directly from the cervix. Glandular involvement of atrophic endometrial glands was observed, however no invasive growth was observed in the endometrium in either case. Immunohistochemical studies revealed that CD138 was strongly expressed in the carcinoma cells superficially spreading in the endometrium in the two cases. It has been reported that the loss of expression of CD138, a cell-surface heparan sulfate proteoglycan participating in cell-cell and cell-extracellular matrix interactions, is correlated with tumor invasion and progression to cervical SCC. Our present findings suggest that CD138 expression in carcinoma cells may participate in superficial spread by regulating cell-cell interactions.

Entities:  

Year:  2012        PMID: 23255888      PMCID: PMC3525468          DOI: 10.3892/ol.2012.953

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  10 in total

Review 1.  Functions of cell surface heparan sulfate proteoglycans.

Authors:  M Bernfield; M Götte; P W Park; O Reizes; M L Fitzgerald; J Lincecum; M Zako
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

2.  Loss of cell-surface heparan sulfate expression in both cervical intraepithelial neoplasm and invasive cervical cancer.

Authors:  Yasuhiro Shinyo; Junichi Kodama; Tomoyuki Kusumoto; Yuji Hiramatsu
Journal:  Gynecol Oncol       Date:  2005-03       Impact factor: 5.482

3.  Syndecan-1 expression in cancer of the uterine cervix: association with lymph node metastasis.

Authors:  Fumitaka Numa; Kei Hirabayashi; Keiko Kawasaki; Yuko Sakaguchi; Norihiro Sugino; Yutaka Suehiro; Yoshinori Suminami; Hiroshi Hirakawa; Kenji Umayahara; Shugo Nawata; Hidenobu Ogata; Hiroshi Kato
Journal:  Int J Oncol       Date:  2002-01       Impact factor: 5.650

Review 4.  Unusual form of superficial spreading squamous cell carcinoma of cervix involving the endometrium, bilateral tubes and ovaries: a case report with literature review.

Authors:  Tayfun Gungor; Sunduz Ozlem Altinkaya; Mustafa Ozat; Serap Akbay; Leyla Mollamahmutoglu
Journal:  Arch Gynecol Obstet       Date:  2010-09-18       Impact factor: 2.344

5.  Cervical squamous cell carcinoma in situ with intraepithelial extension to the upper genital tract and invasion of tubes and ovaries: report of a case with human papilloma virus analysis.

Authors:  M R Pins; R H Young; C P Crum; I H Leach; R E Scully
Journal:  Int J Gynecol Pathol       Date:  1997-07       Impact factor: 2.762

6.  Simultaneous squamous cell carcinomas of the uterine cervix and upper genital tract: loss of heterozygosity analysis demonstrates clonal neoplasms of cervical origin.

Authors:  M Kushima; H Fujii; K Murakami; H Ota; T Matsumoto; T Motoyama; T Kiyokawa; H Ishikura
Journal:  Int J Gynecol Pathol       Date:  2001-10       Impact factor: 2.762

Review 7.  Unusual form of superficial spreading microinvasive squamous cell carcinoma of uterine cervix involving the endometrium of uterus.

Authors:  Geok Chin Tan; Mohamed Rose Isa; Soon Pheng Ng; Yassin Muhd Abd Jamil
Journal:  J Obstet Gynaecol Res       Date:  2004-10       Impact factor: 1.730

8.  Syndecan-1 enhances the endometrial cancer invasion by modulating matrix metalloproteinase-9 expression through nuclear factor kappaB.

Authors:  Jeong-Hyun Oh; Ji-Hye Kim; Hak-Jun Ahn; Jong-Hyuck Yoon; Seung-Chul Yoo; Dong-Soon Choi; In-Seon Lee; Hee-Sug Ryu; Churl K Min
Journal:  Gynecol Oncol       Date:  2009-06-17       Impact factor: 5.482

9.  Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.

Authors:  E June Davies; Fiona H Blackhall; Jonathan H Shanks; Guido David; Alan T McGown; Ric Swindell; Richard J Slade; Pierre Martin-Hirsch; John T Gallagher; Gordon C Jayson
Journal:  Clin Cancer Res       Date:  2004-08-01       Impact factor: 12.531

10.  Prognostic significance of syndecan-1 expression in cervical cancers.

Authors:  Yu Im Kim; Ahwon Lee; Bum Hee Lee; Su Young Kim
Journal:  J Gynecol Oncol       Date:  2011-09-28       Impact factor: 4.401

  10 in total
  4 in total

1.  Primary Endometrial Squamous Cell Carcinoma In Situ: Report of a rare disease.

Authors:  Sujata Jetley; Zeeba S Jairajpuri; Mohammad J Hassan; Garima Madaan; Reena Jain
Journal:  Sultan Qaboos Univ Med J       Date:  2015-11-23

Review 2.  Superficial spreading cervical squamous cell carcinoma in situ involving the endometrium: a case report and review of the literature.

Authors:  Javier Martín-Vallejo; Juan B Laforga; Patricia Molina-Bellido; Pedro A Clemente-Pérez
Journal:  J Med Case Rep       Date:  2022-05-20

3.  Squamous Cell Carcinoma In situ of the Cervix with Superficial Intraepithelial Extension to the Endometrium of Lower Uterine Segment: A Rare Presentation.

Authors:  Rajeshwari K Muthusamy; Sangita S Mehta
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Jan-Mar

4.  Endometrial squamous cell carcinoma originating from the cervix: A case report.

Authors:  Xin-Yu Shu; Zhang Dai; Shuang Zhang; Hui-Xia Yang; Hui Bi
Journal:  World J Clin Cases       Date:  2022-08-26       Impact factor: 1.534

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.